logo

Part two: an unblinded, parallel, randomized study to assess nicotine pharmacokinetics of four Vuse Solo ENDS flavors in smokers.

Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics

Keyser (2023)

Tracing the movement of electronic cigarette flavor chemicals and nicotine from refill fluids to aerosol, lungs, exhale, and the environment.

Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics

Khachatoorian (2022)

Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders.

Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics

Laviolette (2021)

Inhibition of human Liver Microsomal (S)-Nicotine Oxidation by (−)-Menthol and analogues

Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics

MacDougall (2003)

Nicotine and Cotinine Levels With Electronic Cigarette: a Review

Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics

Marsot and Simon (2016)